2018 AUA Annual Meeting

ICU Theater

0 results found.

Type here to filter the list

Friday, May 4, 2018
10:30 AM - 11:30 AM

Opportunities to Improve the Quality of Prostate Cancer Management: Importance of Testosterone Monitoring and the Potential of Big Data
10:30 AM - 11:30 AM

Opportunities to Improve the Quality of Prostate Cancer Management: Importance of Testosterone Monitoring and the Potential of Big Data
ICU Theater

Favorite

Franklin Gaylis ### 214681###Speaker @@@ Evan Goldfischer, MD ### 722089###Speaker
Saturday, May 19, 2018
10:00 AM - 11:00 AM

Lilly Product Theater: Genital Psoriasis Overview
10:00 AM - 11:00 AM

Lilly Product Theater: Genital Psoriasis Overview
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Jennifer Soung, MD ### 542142###Speaker
12:00 PM - 1:00 PM

Continuing Care for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12:00 PM - 1:00 PM

Continuing Care for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Jonathan Silberstein, MD ### 358250###Speaker
1:30 PM - 2:30 PM

Latest Perspectives in OAB Treatment
1:30 PM - 2:30 PM

Latest Perspectives in OAB Treatment
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Scott MacDiarmid ### 215277###Speaker
3:00 PM - 4:00 PM

Noctiva: Addressing A Nighttime Condition with Daytime Consequences
3:00 PM - 4:00 PM

Noctiva: Addressing A Nighttime Condition with Daytime Consequences
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Diane K. Newman, DNP ANP-BC FAAN ### 215481###Speaker @@@ Scott MacDiarmid ### 215277###Speaker @@@ Jennifer U. Miles-Thomas, MD ### 535582###Speaker @@@ Thomas Roth, PhD ### 535583###Speaker
Sunday, May 20, 2018
10:00 AM - 11:00 AM

ERLEADA™ (apalutamide) An androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (CRPC)
10:00 AM - 11:00 AM

ERLEADA™ (apalutamide) An androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (CRPC)
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Jason M. Haphron, MD ### 552077###Presenter @@@ Scott Sellinger ### 539688###Speaker @@@ Jonathan Silberstein, MD ### 358250###Speaker
12:00 PM - 1:00 PM

Elevating Care in Advanced Prostate Cancer
12:00 PM - 1:00 PM

Elevating Care in Advanced Prostate Cancer
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Kenneth M. Kernen, MD ### 358249###Speaker
1:30 PM - 2:30 PM

An Advancement in RCC: Rethink Your Current Practice Following Nephrectomy
1:30 PM - 2:30 PM

An Advancement in RCC: Rethink Your Current Practice Following Nephrectomy
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Alexander Kutikov ### 523702###Speaker @@@ Steven Canfield, MD ### 535606###Speaker
3:00 PM - 4:00 PM

BPH Symposium Phase 3 Clinical Studies and Biology of Fexapotide Triflutate Office Injectable for BPH
3:00 PM - 4:00 PM

BPH Symposium Phase 3 Clinical Studies and Biology of Fexapotide Triflutate Office Injectable for BPH
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Ronald Tutrone, MD, FACS ### 535847###Speaker @@@ Mohamed Bidair, MD ### 535856###Speaker @@@ Alan Hay, MD, FACS ### 535881###Speaker @@@ Jeffrey Snyder, MD ### 535896###Speaker @@@ Ivan Grunberger, MD, FACS ### 382696###Speaker @@@ Susan J. Kalota, MD ### 484990###Speaker
Monday, May 21, 2018
12:00 PM - 1:00 PM

A Treatment Option for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma
12:00 PM - 1:00 PM

A Treatment Option for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Location: ICU Theater, Booth #5366 in Hall D
ICU Theater

Favorite

Neal D. Shore, MD, FACS ### 215884###Speaker